Table 4.
FKA mg/kg | GST(nmol/min/mg)
|
||||
---|---|---|---|---|---|
0 | 3 | 7 | 15(days of administration) | ||
liver | 0 | 729.47±33.87 | 740.10±112.58 | 691.56±86.74 | 756.76±83.00 |
100 | 1191.81±235.47* | 711.04±25.47 | 1203.04±243.90* | ||
200 | 1015.37±108.39* | 700.25±62.66 | 1013.56±107.02* | ||
bladder | 0 | 450.71±18.20 | 444.29±44.89 | 471.15±108.47 | 436.58±55.70 |
100 | 746.65±134.09* | 520.07±99.02 | 488.46±63.37 | ||
200 | 759.97±67.51* | 564.10±76.31 | 434.44±48.89 | ||
prostate | 0 | 208.93±4.62 | 205.41±85.90 | 207.2352±11.59 | 214.17±23.70 |
100 | 233.77±86.73 | 198.486±15.16 | 230.93±41.64 | ||
200 | 239.19±90.09 | 201.506±23.59 | 220.78±19.94 | ||
lung | 0 | 229.89±10.54 | 217.91±11.30 | 237.75±44.33 | 234.02±101.90 |
100 | 188.04±43.10 | 228.28±35.06 | 230.62±20.06 | ||
200 | 233.59±28.391 | 275.74±10.79 | 265.59±56.67* | ||
stomach | 0 | 169.84±6.27 | 163.94±27.03 | 176.44±64.28 | 169.14±13.58 |
100 | 194.46±13.51 | 211.20±31.71 | 223.55±15.44* | ||
200 | 232.99±46.97* | 214.10±14.58 | 220.38±18.62* | ||
Small intestine | 0 | 242.88±16.18 | 224.68±39.81 | 248.30±34.72 | 255.67±42.49 |
100 | 273.20±19.50* | 393.39±105.97* | 307.94±17.81* | ||
200 | 296.34±22.11* | 394.84±50.59* | 274.42±39.89 |
The data shown are means ± SD of five independent mice.
Statistically significant versus control group, P < 0.05 (t-test).